A robust list of ongoing projects making use of U-BIOPRED data

U-BIOPRED project Coordinators update 3/6/2022.

Biobank: The efforts to move the biobank from Manchester to the AZ continue with contracting, sample audits and planning. This will help secure the biobank resource for future use. The plan is to have the move occur in September.

Seminars: The seminars in June will focus on reviewing ongoing projects. In total when you add in the accelerant projects there are 64 ongoing projects. Not everyone has responded to the request to send in their projects. This underscores the value of the U-BIOPRED dataset and more importantly the value of working together. The best papers happen when people join ongoing efforts by adding in their technique, additional data, or expertise. The papers most likely to get published combine the methods and techniques from multiple different sources to answer multiple research questions.

On June 16th and 30th we will have a review and presentations of the projects on the list. They will also be an opportunity for you to discuss the projects, offer your help for existing projects, or propose new ones.

Data work: Nazanin from Imperial College is working to check with platform leads to assure that the datasets are in order and that all datasets are present. This will lead to an update of the tranSMART database

TranSMART Masterclass: The next Masterclass will be an exploratory analysis looking at the transcription-associated clusters (TACS) in blood with the bronchial brushing and biopsy data. The date will be determined sometime in September. Let us know if you are interested in this Masterclass so we can try to align it with your schedule.

C-Path and IMI regulatory input: There are ongoing discussions with the C-Path and IMI about the U-BIOPRED approach and dataset.

Do you know of an organisation that would benefit from these types of meaningful interactions? U-BIOPRED is part of the Precision Medicine BioPharma X distributed translational ecosystem? Email us here to find out more.

Previous
Previous

Innovative Health Initiative (IHI) and precision medicine